Abstract:Objective To investigate the synergetic role in inducing apoptosis of osteosarcoma cell(MG-63)when tumor necrosis factor-related apoptosis inducing ligand(TRAIL)combined with interferon(IFN)-γ.to explore the potential mechanism of synergistic antitumor activity,and to observe the toxicity of TRAIL combined with IFN-γin fibroblast.Methods The mor- pholngy was observed with inverted phase contrast microscope and electronic microscope after MC-63 was treated by TRATL, IFN-γ,and TRAIL combined with IFN-γRespectively inhibition rate and apoptosis rate was assessed by methyl thiazolyl tet- razolizm(MTT)assay and flow cytometer(FCM).After MG-63 was intervened by IFN-γ.the expression of TRAIL receptors was detected by Reverse Transcription-Polymerase Chain Reaction(RT-PCR).The toxicity of TRAIL combined with IFN-γin fihro- blast was evaluated by MTT assay.Results The growth activity of MG-63 was weakened after it was intervened by TRAIL com- bined with IFN-γ.When it was treated by IFN-γfor 24 hours,then combined with TRAIL,it showed the lowest activity.The Electronic microscope could reveal the apoptosis characteristic changes.The inhibition rate of MG-63 increased obviously by combi- ning TRAIL and IFN-γ,comparing with administration of TRAIL alone,and the difference was statistically significant(P0.01).The apoptosis rate of MG-63 increased obviously by combining TRAIL and IFN-γ,and the difference was significant(P0.01).The expression of death receptor(DR)4 was increased significantly(P0.01)when MG-63 had been treated with IFN-γfor 24 hours.The toxicity of TRAIL combined with IFN-γin fibroblast was not increased(P0.05).Conclusions IFN-γhad synergetic role in the apoptosis effect induced by TRAIL in MG-63.Up-regulating DR4 might he one of the reasons for synergetic antitumor activity.The risk of toxicity in fibroblast was not raised when TRAIL combined with IFN-γ.

Activity of TRAIL Gene Modification Combined with DOX on Human Colon Cancer Cell Line RKO

Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells

Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

Tumor Suppression Activity of Ginsenoside Rg3 Combined with TRAIL Gene on Human Colon Cancer Cell Line HCE8693

Effects of Different Chemotherapeutic Agents on Reversing the Acquired Resistance to TRAIL Gene in DLD1 Colon Cancer Cells

Targeted Expression of Green Fluorescent Protein/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Fusion Protein from Human Telomerase Reverse Transcriptase Promoter Elicits Antitumor Activity Without Toxic Effects on Primary Human Hepatocytes

[Activity of the TNF-related Apoptosis-Inducing Ligand Gene Expressed from the Htert Promoter on Colon Cancer Cell Line HT-29].

Cell To Cell Contact Required For Bystander Effect Of The Tnf-Related Apoptosis-Inducing Ligand (Trail) Gene

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

Combination of PHA-767491 with TRAIL Inhibits Proliferation of Hepatocellular Carcinoma Bel-7404 Cells

Overcoming Acquired TRAIL Resistance in Human Colon Cancer by Proteasome Inhibitor Bortezomib

A Study on the Activity of Htert Promoter Related Tumor Targeting Gene on Colon Cancer Cell Line DLD-1

Anti-liver Cancer Activity of TNF-related Apoptosis-Inducing Ligand Gene and Its Bystander Effects.

Changes and Significance of Fas and Cflip in Apoptosis of Human Rhabdomyosarcoma Cells Induced by Combination of TRAIL and Cisplatin

Proteasome Inhibitor MG132 Enhances TRAIL-induced Apoptosis and Inhibits Invasion of Human Osteosarcoma OS732 Cells

The inducible TRAIL and its death receptors expression induced by IFN-γ in RKO cell line

Experimental Study on Apoptosis of Osteosarcoma Cell Induced by TRAIL Combined with IFN-γ

Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter